Keyphrases
Early Breast Cancer
100%
Gene Expression Alterations
100%
Estrogen Receptor-positive
100%
Aromatase Inhibitors
100%
Trefoil Factor 3 (TFF3)
100%
Breast Cancer Patients
100%
Estrogen Receptor-positive Breast Cancer
33%
Quantitative PCR
22%
Inhibitor Resistant
22%
Altered Expression
22%
Monotherapy
22%
Small Interfering RNA (siRNA)
22%
Overexpression
22%
Tamoxifen Resistance
11%
Non-recurrent
11%
Chemotherapy
11%
MCF-7
11%
Metastasis
11%
Adjuvant Therapy
11%
Growth Signaling
11%
Cell Line Models
11%
Clinical Problems
11%
Cellular Growth
11%
Cell Development
11%
Functional Studies
11%
Reduced Sensitivity
11%
Global Gene Expression Analysis
11%
Functional Role
11%
Oncogene
11%
Survival Signaling
11%
Promoting Effect
11%
Primary Breast Cancer
11%
Gene Knockout
11%
Cell Growth
11%
Inhibitor Treatment
11%
Cell Proliferation
11%
Estrogen-responsive
11%
Overall Survival
11%
Six Genes
11%
Resistant Cell Lines
11%
Effects on Growth
11%
Recurrent Disease
11%
Tumor
11%
Growth Inhibition
11%
DACH1
11%
Medicine and Dentistry
Gene Expression
100%
Aromatase Inhibitor
100%
Estrogen Receptor
100%
Breast Cancer
100%
Estrogen Receptor Positive Breast Cancer
33%
Recurrent Disease
33%
Small Interfering RNA
22%
Monotherapy
22%
Cell Growth
22%
Quantitative Reverse Transcription Polymerase Chain Reaction
22%
Gene Expression Profiling
11%
Neoplasm
11%
Biological Marker
11%
Adjuvant Therapy
11%
Cell Line
11%
Metastatic Carcinoma
11%
Oncogene
11%
Overall Survival
11%
Trefoil Factor 3
11%
Cell Proliferation
11%
MCF-7
11%
Resistant Cell Line
11%
Gene Knockdown
11%
Cell Maturation
11%
Growth, Development and Aging
11%
Tamoxifen
11%
Immunology and Microbiology
Aromatase
100%
Gene Expression
100%
Quantitative Reverse Transcription Polymerase Chain Reaction
22%
Cell Growth
22%
Gene Expression Assay
11%
Overall Survival
11%
Cell Line
11%
Resistant Cell Line
11%
Cell Proliferation
11%
Oncogene
11%
Cell Maturation
11%
Trefoil Factor 3
11%
Growth, Development and Aging
11%
Biochemistry, Genetics and Molecular Biology
Aromatase Inhibitor
100%
Exemestane
33%
Trefoil Factor 3
11%
RGS5
11%
Pharmacology, Toxicology and Pharmaceutical Science
Exemestane
33%
Trefoil Factor 3
11%